[SRNE] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -126.76%
YoY- -420.65%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 6,143 6,929 4,105 3,913 6,246 20,407 121,910 -86.38%
PBT -145,810 -55,746 -50,380 -74,081 -33,574 -38,001 94,953 -
Tax -178 -3,122 -826 -1,377 -948 -90,424 57,480 -
NP -108,071 -49,776 -47,328 -73,864 -32,574 12,425 33,959 -
Tax Rate - - - - - - -60.54% -
Total Cost 114,214 56,705 51,433 77,777 38,820 7,982 87,951 19.04%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -1,759.25 -718.37 -1,152.94 -1,887.66 -521.52 60.89 27.86 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -0.88 -0.41 -0.40 -0.73 -0.38 0.15 0.44 -
EPS Diluted -0.88 -0.41 -0.40 -0.73 -0.38 0.15 0.44 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.